7Baggers
 Artelo Biosciences closes $2 million public offering By Investing.com  Investing.com UK Wed, 01 Oct 2025 20:12:00 GMT
 Artelo Biosciences Announces Closing of $2.0 Million Public Offering  GlobeNewswire Wed, 01 Oct 2025 20:11:52 GMT
 artelo biosciences announces pricing of $2.0 million public offering  GlobeNewswire Tue, 30 Sep 2025 12:35:38 GMT
 Form 424B5 ARTELO BIOSCIENCES, INC.  StreetInsider Tue, 30 Sep 2025 11:33:38 GMT
 Artelo Biosciences Announces Proposed Underwritten Public Offering  The Manila Times Tue, 30 Sep 2025 09:39:39 GMT
 artelo biosciences launches underwritten public offering of stock by investing.com  Investing.com Australia Mon, 29 Sep 2025 23:54:17 GMT
 Artelo Biosciences Announces Proposed Underwritten Public Offering  GlobeNewswire Mon, 29 Sep 2025 23:18:04 GMT
 Artelo Biosciences (ARTL) Shares Promising Interim Data from Pha  GuruFocus Mon, 29 Sep 2025 13:43:34 GMT
 Artelo Biosciences Announces Presentation of Positive  GlobeNewswire Mon, 29 Sep 2025 12:34:27 GMT
 artelo biosciences ends securities purchase agreement  MSN Thu, 18 Sep 2025 20:15:38 GMT
 artelo biosciences completes stock offering with over-allotment  TipRanks Tue, 16 Sep 2025 01:36:28 GMT
 Artelo Biosciences Completes Stock Offering with Over-Allotment  TipRanks Mon, 15 Sep 2025 07:00:00 GMT
 artelo biosciences approves common stock increase  MSN Sun, 14 Sep 2025 09:21:59 GMT
 artelo biosciences approves common stock increase  MSN Thu, 11 Sep 2025 02:08:44 GMT
 artl - artelo biosciences inc latest stock news & market updates  Stock Titan Wed, 10 Sep 2025 12:30:00 GMT
 Artelo Biosciences Updates Bylaws on September 9, 2025  TipRanks Wed, 10 Sep 2025 07:00:00 GMT
 artelo biosciences announces closing of $3.0 million public offering  MarketScreener Mon, 08 Sep 2025 14:33:16 GMT
 artelo biosciences (artl) downgraded to hold by d. boral capital  GuruFocus Mon, 08 Sep 2025 12:32:30 GMT
 published on: 2025-09-06 13:10:32  Newser Sat, 06 Sep 2025 18:10:32 GMT
 artelo biosciences announces closing of $3.0 million public offering  The Manila Times Sat, 06 Sep 2025 07:00:00 GMT
 artelo biosciences completes $3 million public offering  AInvest Fri, 05 Sep 2025 20:06:03 GMT
 form 424b5 artelo biosciences, inc.  StreetInsider Fri, 05 Sep 2025 15:56:57 GMT
 Artelo Biosciences Announces Closing of $3.0 Million Public Offering  GlobeNewswire Fri, 05 Sep 2025 07:00:00 GMT
 artelo biosciences approves common stock increase  MSN Fri, 05 Sep 2025 00:12:34 GMT
 form 424b5 artelo biosciences, inc.  StreetInsider Thu, 04 Sep 2025 11:38:12 GMT
 Artelo Biosciences Announces Pricing of $3.0 Million Public Offering  GlobeNewswire Thu, 04 Sep 2025 07:00:00 GMT
 Artelo Biosciences prices $3 million public offering of common stock  Investing.com Thu, 04 Sep 2025 07:00:00 GMT
 Artelo’s cancer cachexia drug succeeds in Phase II  Clinical Trials Arena Thu, 04 Sep 2025 07:00:00 GMT
 artelo biosciences prices $3 million offering; shares fall 50% pre-bell  MarketScreener Thu, 04 Sep 2025 07:00:00 GMT
 artelo biosciences launches public offering of common stock by investing.com  Investing.com Canada Thu, 04 Sep 2025 06:31:40 GMT
 artelo biosciences announces interim phase 2 cares results  TipRanks Wed, 03 Sep 2025 13:41:18 GMT
 Artelo Biosciences Announces Proposed Underwritten Public Offering  GlobeNewswire Wed, 03 Sep 2025 07:00:00 GMT
 Artelo Biosciences Announces Positive Interim Phase 2 CAReS  GlobeNewswire Wed, 03 Sep 2025 07:00:00 GMT
 Artelo Biosciences launches public offering of common stock  Investing.com Wed, 03 Sep 2025 07:00:00 GMT
 published on: 2025-09-02 13:42:59  Newser Tue, 02 Sep 2025 18:42:59 GMT
 artelo biosciences approves common stock increase  TipRanks Fri, 29 Aug 2025 07:00:00 GMT
 artelo biosciences approves common stock increase  MSN Thu, 28 Aug 2025 07:00:00 GMT

Artelo Biosciences, Inc
(NASDAQ:ARTL) 

ARTL stock logo

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1 clinical trial for ...

Founded: 2011
CEO: Gregory Gorgas  
Sector: Manufacturing
Industry: Tobacco Manufacturing

Share this website to your friends